1.

In December 2020, which company has partnered with Russia’s Gamaleya Research Institute, (RDIF) and R-Pharm to assess the safety and immunogenicity of a combination of their respective adenovirus-vector vaccines AZD1222 and Sputnik V?

A. bharat biotech
B. AstraZeneca
C. Biocon
D. Syngene International Limited
E. Cadila Healthcare
Answer» C. Biocon


Discussion

No Comment Found